ReShape Lifesciences. has filed a patent for an intragastric balloon system to treat obesity. The system includes a swallowable capsule containing a balloon with self-sealing and degradable valves for controlled deflation. The device aims to provide a minimally invasive method for weight loss. GlobalData’s report on ReShape Lifesciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights ReShape Lifesciences Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on ReShape Lifesciences, Ostomy monitoring system was a key innovation area identified from patents. ReShape Lifesciences's grant share as of January 2024 was 47%. Grant share is based on the ratio of number of grants to total number of patents.

Intragastric balloon system for treating obesity

Source: United States Patent and Trademark Office (USPTO). Credit: ReShape Lifesciences Inc

The patent application (Publication Number: US20240016635A1) describes an intragastric balloon system designed to be swallowable by a patient and degrade in the gastric environment. The system includes a balloon compacted within a capsule, with separate fill and release valves. The release valve is designed to degrade in response to liquid in the balloon, allowing the liquid to deflate the balloon and pass into the gastric environment. The system aims to deflate the balloon between 1 to 6 months after inflation, facilitating its passage through the digestive tract.

Furthermore, the intragastric balloon system features a self-sealing fill valve, ensuring the balloon remains inflated until the release valve degrades. The release valve's degradation is triggered by the internal environment of the balloon, with components designed to break down based on factors like pH, humidity, or the liquid present. The system's innovative design allows for controlled deflation and eventual excretion of the balloon, enhancing patient comfort and safety during the weight loss procedure.

To know more about GlobalData’s detailed insights on ReShape Lifesciences, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies